Anti-LRP4 Autoantibodies
Abstract
INTRODUCTION: We assessed antibodies against low-density lipoprotein receptor-related protein 4 (LRP4-Ab) in a Chinese population with myasthenia gravis (MG).
METHODS: Serum samples from 116 patients and 80 controls were collected. Acetylcholine receptor antibodies(AChR-Ab) and muscle-specific receptor tyrosine kinase antibodies (MuSK-Ab) were tested using an enzyme-linked immune absorption assay, and LRP4-Ab was identified using a cell-based assay. MG patients with neither AChR-Ab nor MuSK-Ab were defined as double-seronegative MG (dSN-MG).
RESULTS: Two of 116 (1.7%) of all patients and 2 of 50 (1%) dSN-MG patients were positive for LRP4-Ab. These 2 patients had ocular MG. Following treatment with acetylcholinesterase inhibitor and prednisone, both achieved full remission.
CONCLUSIONS: This study shows that LRP4-Ab is a pathogenic antibody in MG. LRP4-MG seems to be characterized by mild disease severity and favorable therapeutic effect in contrast with other types of MG. Muscle Nerve, 2017.
© 2017 Wiley Periodicals, Inc.Similar articles
- Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.Zhang B, et al. Arch Neurol. 2012.
- A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.Zisimopoulou P, et al. J Autoimmun. 2014.
- Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.Marino M, et al. PLoS One. 2015.
- [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].Review articleOhta R, et al. Rinsho Byori. 2014.
- [Autoantibodies in myasthenia gravis].Review articleMotomura M, et al. Brain Nerve. 2013.
Comments
Post a Comment